Trajectories of switching to optimise efficacy and minimising risks in patients with moderate-to-severe plaque psoriasis: results from the PsoReal registry

Arch Dermatol Res. 2024 May 25;316(6):263. doi: 10.1007/s00403-024-02967-5.

Elena Pezzolo^{1

2

3}, Simone Cazzaniga^{4

5}, Fortunato Cassalia^{4

6}, Sara Di Leo⁶, Luigi Naldi^{4

6}

¹ Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED), Bergamo, Italy. [email protected].
² Department of Dermatology, San Bortolo Hospital, Vicenza, Italy. [email protected].
³ Unità Complessa di Dermatologia, AULSS 8, Ospedale san Bortolo, viale Rodolfi 37, Vicenza, 36100, Italy. [email protected].
⁴ Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.
⁵ Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland.
⁶ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.

No abstract available

Publication types